|Podcasts|January 23, 2018
Episode 1: 2018 Trends
Author(s)Michelle Maskaly, Christen Harm
In this podcast, Pharmaceutical Executive editors, Christen Harm and Michelle Maskaly, discuss the 2018 pharma trends, specifically biosimilars and eEnablement, and takeaways from the 2017 Veeva European Commercial Summit.
Advertisement
In this episode, Pharmaceutical Executive editors discuss the 2018 pharma trends, specifically biosimilars and eEnablement, and takeaways from the 2017 Veeva European Commercial Summit.
The podcast can be downloaded directly from SoundCloud, iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharma and MedTech Rarely Collide. That Might Be the Biggest Miss in Healthcare
2
Insilico Medicine Enters $120 Million Drug Development Collaboration with Qilu Pharmaceuticals to Advance Cardiometabolic Therapies
3
Seamless Therapeutics Enters $1.12 Billion Global Research Collaboration with Eli Lilly to Develop Therapeutics for Hearing Loss
4
Pharmaceutical Executive Daily: Eli Lilly Enters $1 Billion Research Collaboration with Seamless Therapeutics
5